Dr. Bradford Wood Joins DeepSight as VP of Strategic Partnerships

DeepSight Welcomes Dr. Bradford Wood

In an exciting development for the field of interventional radiology, DeepSight Technology has announced the appointment of Dr. Bradford Wood, MD as Vice President of Strategic Partnerships. Dr. Wood previously served as the Founding Director of the NIH Center for Interventional Oncology and Chief of Interventional Radiology, making him a notable figure in this domain.

A Legacy of Innovation

Dr. Wood has a rich history in advancing interventional procedures, focusing on innovative therapies that lessen invasiveness. With over 60 patents and more than 700 published papers—including a remarkable H-index of 115—his contributions to the medical field are noteworthy. His leadership in research and partnerships has significantly impacted both public and private sectors, shaping the future of minimally invasive procedures and precision medicine globally.

In his new role at DeepSight, Dr. Wood's primary focus will be on leading collaborations with hospitals, research institutions, and industry partners. This is aimed at enhancing the adoption of the company’s cutting-edge NeedleVue™ systems and future imaging technologies. His vast experience will not only assist in creating impactful clinical evidence but will also aid in developing training programs that enhance accessibility to advanced technologies, ultimately improving patient outcomes during interventional procedures.

A Transformative Vision

Dr. Wood expressed enthusiasm about his new position, stating, "It is rare to encounter a transformative technology capable of truly reshaping procedural medicine. DeepSight's platform is a paradigm-shifting technology and a transformational step forward in how we deliver, target, refine, and monitor image-guided procedures. It's like turning on your headlights while driving fast on a curved mountain road at night. Imagine tracking, tissue characterization, temperature, margin definition, and imaging—all from the tip of a needle or a 50-micron flexible strand integrated into internal devices. This is just so cool!"

Leadership Support

Nader Sadrzadeh, CEO of DeepSight, also shared his excitement about Dr. Wood joining their team. He remarked, "We’re thrilled and honored to have Brad as part of the DeepSight journey. His conviction in our vision underscores the transformative impact this technology can have on patient care. We are grateful for his leadership and excited for what’s ahead!"

DeepSight's Commitment

DeepSight Technology is at the forefront of pioneering next-generation interventional ultrasound specifically designed for minimally invasive surgeries and needle-based therapeutics. Their FDA-cleared NeedleVue™ LC1 system integrates proprietary sensor technology to ensure precise, real-time instrument visualization. This technology aims to improve surgical outcomes and efficiency while decreasing reliance on radiation imaging methods, ultimately expanding access to advanced healthcare globally.

As DeepSight continues to enhance its leadership team, the addition of Dr. Wood is poised to drive further progress in the company's mission of transforming interventional medicine. The future looks bright as they work towards broader clinical adoption of innovative technology that stands to benefit countless patients worldwide.

For more information about DeepSight Technology and their innovative solutions, visit DeepSight Technology’s website.